Results 121 to 130 of about 20,176 (178)

Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Goh S, Huh KY, Lee S, Cho JY, Yu KS.
europepmc   +1 more source

Prevalence of substances with OATP1B1 inhibitory properties in individual case safety reports of suspected statin-associated myopathy - an analysis of Swiss pharmacovigilance data. [PDF]

Eur J Clin Pharmacol
Stäuble CK, Toma V, Stammschulte T, Allemann SS, Meyer Zu Schwabedissen HE.   +4 more
europepmc   +1 more source

Sustained Action of Imapextide, A Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers.

J Clin Endocrinol Metab
Fabbrini E, Koshkina A, Hackett M, Zhao M, Thalluri K, Hompesch M, Macias A, Schneider K, D'Alessio DA, DiMarchi RD, Azoulay S.   +10 more
europepmc   +1 more source

Pharmacologic Modulation of the PAR-2-ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells. [PDF]

Int J Mol Sci
Amiri L, Patnaik R, Varghese RL, Huda B, Banerjee Y.   +4 more
europepmc   +1 more source

Biochemical urine analysis of atorvastatin and rosuvastatin by LC-MS: a pilot study of an objective method to assess non-adherence. [PDF]

BMC Cardiovasc Disord
Brockmeyer M, Chernyak N, Dröge D, Wessel H, Parco C, Hoss A, Vargas KG, Lin Y, Rickert A, Ritz S, Icks A, Kelm M, Wolff G, Temme O.   +13 more
europepmc   +1 more source

Effects of rosuvastatin and atorvastatin treatment on ET-1, ADMA, and safety efficacy in elderly patients with coronary heart disease combined with hyperlipidemia. [PDF]

Open Life Sci
Xu T.
europepmc   +1 more source

Dicloxacillin and Flucloxacillin Inhibit Hepatic Uptake Transporters-In Vitro Investigations and Physiologically Based Pharmacokinetic Modeling. [PDF]

Clin Transl Sci
Sjöstedt N, Amaeze OU, van den Heuvel JJMW, Stage TB, Koenderink JB, Isoherranen N, Kidron H, Järvinen E.   +7 more
europepmc   +1 more source

Comparing rosuvastatin and atorvastatin on cardiovascular and kidney outcomes in patients with diabetes across chronic kidney disease stages: an emulated target trial in China. [PDF]

EClinicalMedicine
Huang Y, Yang A, Shi M, Wu H, Ke C, Yu J, Lui JN, Kong AP, Ma RC, Chan J, Wong RS, Tomlinson B, Luk AO, Chan JC, Chow E.   +14 more
europepmc   +1 more source

A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease. [PDF]

Am J Cardiovasc Drugs
Liu HH, Liu ZH, Chen SS, Zhu CG, Li JJ.
europepmc   +1 more source

Statin intensity, prescribing patterns, and LDL‑C reduction following ACS and in CCD patients who underwent PCI in a tertiary care setting. [PDF]

BMC Cardiovasc Disord
Abdelrady S, Zachariah S, Mathew S, Ghannem K.   +3 more
europepmc   +1 more source